文献速递头颈外科

头颈癌根治性放疗完成前接受生存者照护与肿瘤学结局的关联

Survivorship Care Before Completion of Definitive Radiotherapy and Oncologic Outcomes in Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-10-22

该回顾性队列研究纳入2018年3月21日至2025年3月25日在一家学术中心完成根治性放疗的471例头颈癌患者,评估放疗完成前参加多学科生存者照护门诊与放疗依从性及生存结局的关联。多变量分析显示,参加者放疗不依从 odds 更低(OR 0.45,95%CI 0.27-0.75)、3年复发风险更低(SHR 0.62,95%CI 0.40-0.94)、3年无病生存更优(HR 0.61,95%CI 0.41-0.91)。

要点

  • 头颈癌根治性放疗完成前参加多学科生存者照护门诊与更好的放疗依从性相关。
  • 早期生存者照护与更低的3年复发风险和更优的3年无病生存相关。
  • 生存者照护或可提前整合至治疗期间,而非仅在治疗结束后。

核心结论

  • 调整临床和社会人口学因素后,头颈癌患者根治性放疗完成前参加多学科生存者照护门诊与放疗依从性改善和生存获益相关。

研究设计与样本

  • 回顾性队列研究,纳入2018年3月21日至2025年3月25日在一家学术中心完成根治性放疗的头颈癌患者471例。
  • 排除接受原发手术者和接受姑息性放疗者。

主要发现

  • 总体队列471例中,女性83例(17.6%),男性388例(82.4%);148例(31.4%)接受早期生存者照护,247例(52.4%)依从放疗。
  • 多变量分析中,参加者放疗不依从的 odds 更低(OR 0.45,95%CI 0.27-0.75)。
  • 参加者3年复发风险更低(SHR 0.62,95%CI 0.40-0.94),3年无病生存更优(HR 0.61,95%CI 0.41-0.91)。

临床怎么用

  • 对接受根治性放疗的头颈癌患者,可考虑在放疗完成前引入多学科生存者照护门诊。
  • 早期生存者照护可能作为改善放疗依从性和生存结局的可调整照护策略。

局限性

  • 本研究为单中心回顾性队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Across cancer populations, a growing and aging survivor population combined with increasing use of multimodal therapy has expanded the need for survivorship care, particularly in head and neck cancer (HNC). Although survivorship begins at diagnosis, survivorship care is often emphasized after treatment completion, and whether earlier integration during treatment is associated with adherence to treatment and survival remains unclear. OBJECTIVE: To evaluate whether early multidisciplinary survivorship care before definitive radiotherapy completion is associated with adherence and survival outcomes. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients diagnosed with HNC who completed definitive curative-intent radiotherapy at an academic center between March 21, 2018, and March 25, 2025. Patients treated with primary surgery and those receiving palliative-intent radiotherapy were excluded. EXPOSURES: Attendance at a multidisciplinary HNC survivorship clinic before radiotherapy completion. Covariates were sex, race, age and marital status at diagnosis, tumor and nodal categories, history of tobacco or alcohol use, insurance status, treatment with systemic therapy, year of diagnosis, Area Deprivation Index national rank, and cancer site. MAIN OUTCOMES AND MEASURES: The primary outcomes were radiotherapy adherence, 3-year recurrence risk, and 3-year disease-free survival (DFS). Radiotherapy adherence was evaluated using logistic regression, DFS using Cox proportional hazards regression, and recurrence using Fine-Gray regression. RESULTS: Among 471 patients in the overall cohort (83 [17.6%] female; 388 [82.4%] male), 148 (31.4%) received early survivorship care, and 247 (52.4%) adhered to radiotherapy. In multivariable analysis adjusting for clinical and sociodemographic factors, attendees had lower odds of radiotherapy nonadherence (odds ratio, 0.45; 95% CI, 0.27-0.75), lower 3-year recurrence risk (subdistribution hazard ratio [SHR], 0.62; 95% CI, 0.40-0.94), and improved 3-year DFS (HR, 0.61; 95% CI, 0.41-0.91). CONCLUSIONS AND RELEVANCE: In this study, after adjustment for clinical and sociodemographic factors, early survivorship care was associated with improved radiotherapy adherence and survival among patients with HNC. These findings suggest that earlier integration of multidisciplinary survivorship care, rather than solely after treatment, may be a modifiable care delivery strategy with potential relevance across cancer populations.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nilsen ML, Carlson KM, Owoc MS, et al. Survivorship Care Before Completion of Definitive Radiotherapy and Oncologic Outcomes in Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42911578. doi:10.1001/jamaoto.2026.3198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。